These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Phase II trial with chlorozotocin in advanced colorectal cancer. Bleiberg H; Rozencweig M; Michel J; Clavel M; Longeval E; Feremans W; Bondue H; Lardinois J; Crespeigne N; Kenis Y Eur J Cancer Clin Oncol; 1981 Aug; 17(8):863-6. PubMed ID: 6459936 [No Abstract] [Full Text] [Related]
28. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer. Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700 [TBL] [Abstract][Full Text] [Related]
29. Nitrosourea chemotherapeutic agents: Chlorozotocin. National Toxicology Program Rep Carcinog; 2011; 12():328-9. PubMed ID: 21860521 [No Abstract] [Full Text] [Related]
34. A phase II study of chlorozotocin in metastatic malignant melanoma. Hoth DF; Schein PS; Winokur S; Woolley PV; Robichaud K; Binder RB; Smith FP Cancer; 1980 Oct; 46(7):1544-7. PubMed ID: 6448088 [TBL] [Abstract][Full Text] [Related]
35. [One hundred and twenty-four cases of diffuse pulmonary disease diagnosed by transbronchial lung biopsy via fiberbronchoscope]. Zhu L; Zhou H; Chen P; Liu Z Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):575-6. PubMed ID: 12080726 [TBL] [Abstract][Full Text] [Related]
36. [Radiation- and chemically-induced respiratory manifestations]. Quoix E; Mornex F; Milleron B; Pauli G Rev Mal Respir; 1997 Nov; 14(5):341-53. PubMed ID: 9480478 [TBL] [Abstract][Full Text] [Related]
37. Phase II evaluation of chlorozotocin in refractory multiple myeloma. Forman WB; Cohen HJ; Bartolucci AA; Manning G Cancer Treat Rep; 1984 Nov; 68(11):1409-10. PubMed ID: 6238673 [No Abstract] [Full Text] [Related]
38. The nitrosoureas and pulmonary toxicity. Weiss RB; Poster DS; Penta JS Cancer Treat Rev; 1981 Jun; 8(2):111-25. PubMed ID: 6454489 [No Abstract] [Full Text] [Related]
39. [Disturbances of pulmonary function and biopsy findings with special reference to open lung biospy of diffuse lung diseases]. Masaki M; Matsui A; Homma A; Onoue M; Koguchi N Naika; 1968 Jun; 21(6):1046-60. PubMed ID: 5704150 [No Abstract] [Full Text] [Related]
40. Phase II study of chlorozotocin in advanced breast cancer. Edmonson JH; Green SJ; Ingle JN; Ahmann DL; Disel HF; Creagan ET Cancer Treat Rep; 1981; 65(5-6):537-8. PubMed ID: 6453648 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]